How is this test different from other multi-cancer early detection (MCED) tests Everlywell offers (e.g., technology used, number of cancers screened, performance)?

Most blood-based early detection approaches focus on methylation alone. Methylation is one useful cancer signal, but it is only one part of the biological picture. Caris Detect takes a broader approach using whole genome sequencing (WGS), whole transcriptome sequencing (WTS), and AI to capture a wider range of cancer-related molecular changes, including: driver mutations, epigenomic alterations, transcriptomic changes, and aneuploidy.